About 1 Trademarks found for “WISTALAB”

Pharmaceutical and medical preparations for the treatment of diseases, illnesses and ailments in humans and animals, namely: neoplasms; neurological diseases, namely Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, dementia with Lewy bodies, Pick's disease, frontotemporal dementia, argyrophilic disease, progressive supranuclear palsy, fronto-temporal dementia, parkinsonism linked to chromosome 17, disinhibition-dementia-parkinsonism-amyotrophy complex, pallido-ponto-nigral degeneration, Guam-ALS syndrome; pallido-nigro-luysian degeneration, cortico-basal degeneration, mild cognitive impairment (MCI), multiple system atrophy, drug-induced parkinsonism, and pure autonomic failure; psychiatric diseases, namely, schizophrenia, mood disorders, anxiety disorders, and cognitive disorders; neurological disorders, namely, mild cognitive impairment, tauopathies, and synucleinopathies; cancer; methemoglobinemia; viral diseases, namely herpes, hepatitis, acquired immune deficiency syndrome, and West Nile virus infection; and protozoal diseases, namely malaria, visceral leishmaniasis; African sleeping sickness, toxoplasmosis, giardiasis, and Chagas' disease; pharmaceutical and medical preparations for the treatment of diseases, illnesses and ailments in humans and animals, namely for use in oncology; and pharmaceutical and medical preparations for the treatment of diseases, illnesses and ailments in humans and animals, namely antibiotics, antivirals, and antiprotozoals; chemical preparations for medical and pharmaceutical purposes, namely for the treatment of diseases, illnesses and ailments in humans and animals, namely: neoplasms; neurological diseases, namely Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, dementia with Lewy bodies, Pick's disease, frontotemporal dementia, argyrophilic disease, progressive supranuclear palsy, fronto-temporal dementia, parkinsonism linked to chromosome 17, disinhibition-dementia-parkinsonism-amyotrophy complex, pallido-ponto-nigral degeneration, Guam-ALS syndrome; pallido-nigro-luysian degeneration, cortico-basal degeneration, mild cognitive impairment (MCI), multiple system atrophy, drug-induced parkinsonism, and pure autonomic failure; psychiatric diseases, namely, schizophrenia, mood disorders, anxiety disorders, and cognitive disorders; neurological disorders, namely, mild cognitive impairment, tauopathies, and synucleinopathies; cancer; methemoglobinemia; viral diseases, namely herpes, hepatitis, acquired immune deficiency syndrome, and West Nile virus infection; and protozoal diseases, namely malaria, visceral leishmaniasis; African sleeping sickness, toxoplasmosis, giardiasis, and Chagas' disease; chemical preparations for medical and pharmaceutical purposes, namely for the treatment of diseases, illnesses and ailments in humans and animals, namely for use in oncology; and chemical preparations for medical and pharmaceutical purposes, namely for the treatment of diseases, illnesses and ailments in humans and animals, namely antibiotics, antivirals, and antiprotozoals; first aid kits and diagnostic kits comprised of pharmaceutical and chemical preparations for the treatment of diseases, illnesses, and ailments in humans and animals, namely: neoplasms; neurological diseases, namely Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, dementia with Lewy bodies, Pick's disease, frontotemporal dementia, argyrophilic disease, progressive supranuclear palsy, fronto-temporal dementia, parkinsonism linked to chromosome 17, disinhibition-dementia-parkinsonism-amyotrophy complex, pallido-ponto-nigral degeneration, Guam-ALS syndrome; pallido-nigro-luysian degeneration, cortico-basal degeneration, mild cognitive impairment (MCI), multiple system atrophy, drug-induced parkinsonism, and pure autonomic failure; psychiatric diseases, namely, schizophrenia, mood disorders, anxiety disorders, and cognitive disorders; neurological disorders, namely, mild cognitive impairment, tauopathies, and synucleinopathies; cancer; methemoglobinemia; viral diseases, namely herpes, hepatitis, acquired immune deficiency syndrome, and West Nile virus infection; and protozoal diseases, namely malaria, visceral leishmaniasis; African sleeping sickness, toxoplasmosis, giardiasis, and Chagas' disease; first aid kits and diagnostic kits comprised of pharmaceutical and chemical preparations for the treatment of diseases, illnesses, and ailments in humans and animals, namely for use in oncology; and first aid kits and diagnostic kits comprised of pharmaceutical and chemical preparations for the treatment of diseases, illnesses, and ailments in humans and animals, namely antibiotics, antivirals, and antiprotozoals; almanacs, booklets, books, catalogues, hand books, journals, manuals, magazines, periodicals, newspapers, pamphlets, leaflets, printed tests, written reports and prospectuses; computer software for facilitating research in the fields of science, medicines, drugs, pharmaceuticals, biology, biotechnology, bioinformatics, clinical development and statistics, laboratory and diagnostic instruments, namely computer software for use in the analysis and diagnosis of medical conditions; pre-recorded CD-ROMS and computer disks containing electronic publications, namely, test reports, magazines and manuals, and information in the fields of pre-clinical, clinical and pharmaceutical research and drug discovery and drug research; computer servers; pre-recorded computer disks containing databases and information in the field of scientific, medical, drug, clinical, pharmaceutical, biological, biotechnical, bioinformatic and statistical research; medical apparatus and instruments for facilitating the analysis of biological and chemical matter in the field of genetic testing, namely blood, brain, urine, cerebrospinal fluid (csf) analysis and testing apparatus; medical apparatus for introducing pharmaceutical preparations into the body, the foregoing for carrying out tests for genetic testing; medical testing apparatus for the analysis of biological and chemical matter, namely apparatus for blood, brain, urine and cerebrospinal fluid (csf) analysis and tests; surgical and medical apparatus and instruments for facilitating the analysis of biological and chemical matter, namely apparatus for blood, brain, urine and cerebrospinal fluid (csf) analysis and tests.

Retail sale of pharmaceutical and medical preparations, chemical preparations for medical and pharmaceutical purposes, scientific, measuring and teaching apparatus and instruments, computer software, surgical and medical apparatus and instruments, apparatus for carrying out tests for medical purposes, scientific and medical apparatus for use in tests, printed matter, books, journals, magazines, leaflets, publications, printed tests, written reports; medical, biological, biotechnological, genetic, laboratory and pharmaceutical research design and development services; research development and design of drugs and medicine, laboratory and medical laboratory research and development services; exploitation of scientific research and technology, preparation of reports of scientific and medical research concerning medicines, pharmaceuticals, genetics, biology, biotechnology and drugs; development of prognostic and diagnostic tools; assessment surveys for health and medical purposes; providing research consultation and information in the fields of medical, pharmaceutical, genetic, biological, drug, clinical, statistical and biotechnological research.